Oxygen therapy for acute myocardial infarction.

Area of Science:

• Cardiology
• Emergency Medicine
• Critical Care

Background:

• Oxygen (O2) is commonly recommended for myocardial infarction (MI) patients.
• Concerns exist regarding potential harm from routine oxygen administration.
• Existing systematic reviews found insufficient evidence on oxygen's effect on heart ischemia or infarct size.

Purpose of the Study:

• To evaluate randomized controlled trials (RCTs) on routine inhaled oxygen in acute myocardial infarction (AMI).
• To determine if oxygen improves patient-centered outcomes, specifically pain and mortality.
• To address the discrepancy between clinical recommendations and trial evidence.

Main Methods:

• Searched multiple databases (Cochrane, MEDLINE, EMBASE, etc.) up to February 2010.
• Included RCTs of suspected/proven AMI patients within 24 hours of onset, comparing inhaled oxygen to air.
• Assessed study quality and risk of bias; primary outcomes were death and pain (analgesic use).

Main Results:

• Three trials with 387 patients were analyzed; 14 deaths occurred.
• Pooled relative risk (RR) of death was 2.88 (95% CI 0.88-9.39) and 3.03 (95% CI 0.93-9.83) for confirmed AMI.
• While suggestive of harm, the small number of deaths limits definitive conclusions; RR for analgesic use was 0.97 (95% CI 0.78-1.20).

Conclusions:

• No conclusive evidence from RCTs supports routine inhaled oxygen in acute myocardial infarction.
• A definitive RCT is urgently needed due to potential harm suggested by current data.
• Clinical practice guidelines recommending routine oxygen may not align with available trial evidence.